Evidence map›Paper›PMID 30545922›Full record

ArticleHaematologica2019

Molecular analysis of a CD19-negative diffuse large B-cell lymphoma.

Lorric Delage, Delphine Manzoni, Charles Quinquenet, Juliette Fontaine, Alizée Maarek, Kaddour Chabane, Isabelle Mosnier, Sandrine Hayette, Evelyne Callet-Bauchu, Beatrice Grange and 2 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Haematologica, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Lorric DelageCancer Research Center of Lyon, INSERM U1052 UMR CNRS 5286, Equipe labellisée Ligue Contre le Cancer, Université de Lyon.
Delphine ManzoniHospices Civils de Lyon, Groupement Hospitalier Sud, Service d'hé-matologie biologique, Pierre-Bénite.
Charles QuinquenetCentre Hospitalier Ardèche Nord, Service de Médecine Interne, Annonay.
Juliette FontaineHospices Civils de Lyon, Groupement Hospitalier Sud, Service d'anatomopathologie, Pierre-Bénite, France.
Alizée MaarekHospices Civils de Lyon, Groupement Hospitalier Sud, Service d'anatomopathologie, Pierre-Bénite, France.
Kaddour ChabaneHospices Civils de Lyon, Groupement Hospitalier Sud, Service d'hé-matologie biologique, Pierre-Bénite.
Isabelle MosnierHospices Civils de Lyon, Groupement Hospitalier Sud, Service d'hé-matologie biologique, Pierre-Bénite.
Sandrine HayetteHospices Civils de Lyon, Groupement Hospitalier Sud, Service d'hé-matologie biologique, Pierre-Bénite.
Evelyne Callet-BauchuCancer Research Center of Lyon, INSERM U1052 UMR CNRS 5286, Equipe labellisée Ligue Contre le Cancer, Université de Lyon.
Beatrice GrangeCancer Research Center of Lyon, INSERM U1052 UMR CNRS 5286, Equipe labellisée Ligue Contre le Cancer, Université de Lyon.
Adriana PlesaHospices Civils de Lyon, Groupement Hospitalier Sud, Service d'hé-matologie biologique, Pierre-Bénite.
Pierre SujobertCancer Research Center of Lyon, INSERM U1052 UMR CNRS 5286, Equipe labellisée Ligue Contre le Cancer, Université de Lyon pierre.sujobert@chu-lyon.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AgedAntigens, CD19Antineoplastic Combined Chemotherapy ProtocolsBiomarkersBiopsyBone MarrowCyclophosphamideDisease SusceptibilityDNA Mutational AnalysisDoxorubicinFemaleHumansImmunohistochemistryImmunophenotypingLymphoma, Large B-Cell, DiffuseMolecular Diagnostic TechniquesAntigens, CD19BiomarkersCD19 molecule, humanCyclophosphamideDoxorubicinPrednisoneR-CHOP protocolRituximabVincristine

Identifiers

PMID30545922
PMCPMC6395315

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.